Eye Floaters

“Floaters” or “muscae volitantes” are common eye problems.

This early form of the degenerative changes of the vitreous 1.) with its irritating shadows of around swirling, cross-linked collagen fibers in the field of vision, hinders greatly the quality of life of those affected. The vitreous body changes through collagen metabolism, so that a nutritive influence here is plausible.

Can a relatively short-term diet bring change to those already affected?

In order to answer this important question scientifically, there have been recent studies on it, the results of which are briefly described below:

Study (2018)

In a case study of 463 patients with vitreous floaters, the success rate was of over 60% with oral suplementation of special micronutrients.

Study design

  • 463 patients with vitreous floaters (VF)
  • Age 15 – 61 years
  • VF symptoms were verified before treatment, patients free from acute and chronic eye and systemic diseases
  • Evaluation of questionnaires after Chi2 test and exact Fisher test before and after 3 months of treatment.

(Scale from 0-4; no disturbance – extreme disturbance)

Treatment

3 months 1 capsule per day with L-lysine (125mg), hesperidin (60mg), citrus flavonoids (23.75mg), vitamin C (40mg) and zinc (5mg);

Results

Little improvement 25,9 %
Moderate improvement 27,6 %
Significant improvement 28,4 % / 64,7 %
Drastic improvement  8,7 % / 90,6 %

  • The supplementation of VF subjects shows a relevant alleviation of floater disorders
  • The results from a large number of patients confirm the supplementation success of previous examinations
  • The improvement in vision seems to be greater in younger patients

1)    Sobol M., Oseka M., Kaercher Th., Schmiedchen B.. Journal of Alzheimer`s Disease 64 (2018), BON conference Abstracts (BON 030), S. 16-17


Study 2013

In 2013, a data collection for the daily intake of VitroCap® capsules over a period of 12 weeks, has been conducted in the ophthalmological practice of Dr.Th. Kaercher, Heidelberg.

24 patients (no control group) were included in the observation. The age range of the patients was 21-81 years. The subjective symptoms were quantified in 5 levels (1- low 5- and extreme discomfort), describing the strength of the perceived interference. In
addition, the patients were questioned about when the disturbances were most apparent. At the end of the supplementation period, the extent of the improvement was documented.

Over 80% of the participants reported that the disturbances in the field of vision were particularly noticed in the morning, in the evening and while reading. The number of adverse effects after intake was reduced significantly at all times.


In assessing whether the symptoms improved after the supplementation with VitroCap®, it was affirmed by 21 patients.

Fig.1) Interference by “floaters”. Average score before (orange) and after VitroCap®-taking on a scale of 1 – 5 results (1 = poor, 5 = extremely)

1.) Gerste RD, Kaercher Th, Pharma_Report, ZPA 344; April 2013

(n = 24)

The level of interference was reduced considerably. Fig.1

 

© 2017 Eye Floaters